When: Bull case scenario

Then: $295.0

HOLD - with specific entry/exit framework: trim 20-30% toward $285-$287, add at $270-$272 zone with max 5% portfolio increment, stop at $266

• Q1 2026 FCF negative $18B: spent $44B capex, generated $26B operating cash flow, plugged gap with $52.77B net debt issuance
• Q4 2025 FCF positive $14.94B (holiday quarter seasonal peak, underlying trajectory deteriorating)
• Net debt $17B against $143B in cash, but total debt nearly doubled from $53B to $119B in single quarter
• Forward EPS estimated 17% lower one year out - aggregated sell-side consensus, not fringe estimate
• Trailing P/E 22x vs forward P/E 27x with negative FCF and decelerating earnings is historically dangerous combination
• PEG ratio 1.46 does not offer margin of safety
• Beta 1.454 means stock falls harder than market on negative catalyst
• Revenue growth 12% decelerated from 12.4% in fiscal 2025, quarterly trend choppy
• MACD histogram peaked at 4.62 on August 5, cooled to 3.9 by August 10 - momentum already fading 5 days after crossover
• RSI printed 72.23 on August 3 (textbook overbought), cooled to 65.87 - no fresh momentum expansion, post-spike digestion
• ATR expanded from ~$7 in late July to $9.13 - 30% increase in realized volatility, not the regime for adding positions
• Bullish consensus is crowded: IBD Stock of the Day, Motley Fool $5T target by 2029, Zacks post-earnings drift, JPMorgan S&P 8000 target
• StockTwits retail sentiment data unavailable - cannot verify retail euphoria level, assume worst case
• Upgrade trigger at $287 on volume with FCF stabilization; downgrade trigger at $266 on volume
• Stop at $266 represents ~1.3x ATR of risk from current levels, appropriate for high-beta name in elevated volatility
• 10 EMA at $266, 50 SMA at $247 provide better risk-reward re-entry levels than chasing at $287+
• Q2 2026 earnings is dominant catalyst; no urgency to commit capital $9 below August 3 high with momentum fading

→ vs aggressive: FCF framing as 'strategic investment' is dangerous - company spent $44B capex, generated $26B operating cash flow, borrowed $52.77B to plug gap; operating engine no longer self-funding growth

→ vs aggressive: Debt comparison to billionaire's mortgage is misleading - total debt nearly doubled from $53B to $119B in one quarter; 85% implied probability of zero Fed rate cuts in 2026 means higher-for-longer interest expense

→ vs aggressive: Wall Street AI capex ROI optimism is unfalsifiable - can always say monetization will come later; verifiable data shows 17% forward EPS decline

→ vs aggressive: Confirmed uptrend does not equal actionable buy signal - momentum indicators showing fading MACD, overbought RSI, elevated 30% ATR increase in volatility

→ vs aggressive: Bullish sentiment consensus is warning sign, not confirmation - IBD, Motley Fool, Zacks, JPMorgan all aligned; crowded trade with limited marginal buyers left

→ vs aggressive: Breakout chase confuses price action with risk management - patient buyer gets better risk-reward at $266 or $247 re-entry levels; asymmetry favors the patient

→ vs aggressive: Expected return calculation biased by stacking four optimistic assumptions (AWS reacceleration, Anthropic monetization, supportive macro, clean Q2 beat) - same input bias as bear case, just opposite direction

HOLD

• Operating margin expanded from 2.4% in 2022 to 13.7% today, demonstrating genuine improvement
• Q4 2025 FCF was positive 14.94 billion; Q1 FCF was negative 18.2 billion — the gap reflects investment cycle, not structural deterioration
• Q1 operating cash flow was 26 billion, confirming cash generation capability
• ROE stands at 30.6% with investment-grade debt cost of 4.5 to 5 percent, making debt service manageable
• Entry zone of 270 to 272 aligns 10 EMA, breakout support, and prior consolidation floor
• Trim zone of 285 to 287 captures melt-up premium without requiring full directional bet
• Stop at 266 respects ATR regime at 1.5x volatility
• Upgrade trigger: above 287 on volume with FCF stabilization (threshold undefined)
• Downgrade trigger: below 266 on volume
• Beta of 1.454 means a 10% market drawdown translates to approximately 14.5% AMZN drawdown
• Conservative analyst's trim recommendation of 20 to 30% into weak-volume pushes toward 285 to 287 is tactically sound
• AWS reacceleration is the linchpin, but 'good enough' growth has not been quantified
• Q2 2026 earnings is the primary catalyst to resolve the forward-looking debate
• FCF trajectory and macro oil situation are the primary risk vectors to monitor
• 50 SMA support at 247 represents downside scenario of approximately 15% drawdown from current levels

→ vs aggressive: Treats future AWS monetization thesis as already-fact, then uses that assumed fact to dismiss present-tense cash flow problems — narrative lock-in rather than analysis

→ vs aggressive: Applies winner's bias to a breakout setup that hasn't resolved; ignores symmetric scenario where breakout fails and reverses to 247 (15% drawdown) versus marginal chase upside to 295

→ vs aggressive: Wave away bond market becoming Amazon's primary AI infrastructure funder; mortgage analogy ignores that debt issuance velocity doubled long-term obligations in a single quarter

→ vs conservative: Treats Q1 FCF of negative 18.2 billion as structural deterioration when it's a seasonal, working-capital-distorted data point

→ vs conservative: Contrarian sentiment framing assumes retail euphoria is extreme based on StockTwits data gap with zero evidence — assumes worst case on missing data

→ vs conservative: Claims debt issuance is setup for next sell-off, which is unfalsifiable in the same manner as aggressive analyst's future monetization thesis

→ vs conservative: Tactical trim recommendation is sound, but wrapped in bearish narrative that overstates downside probability